StonvexLoading…
StonvexStonvexStonvexCore line items from SAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.09B | $2.14B | $2.13B | $2.22B |
Operating Income | $144.88M | $75.97M | $100.00M | $90.79M |
Net Income | $108.47M | $59.70M | $76.25M | $67.26M |
EPS (Diluted) | $9.89 | $5.06 | $6.21 | $5.44 |
Total Assets | $1.19B | $1.25B | $1.43B | $1.42B |
Total Liabilities | $347.31M | $333.83M | $352.06M | $352.22M |
Cash & Equivalents | $223.38M | $211.82M | $298.49M | $180.56M |
Free Cash Flow OCF − CapEx | $215.59M | $172.62M | $201.06M | $109.36M |
Shares Outstanding | 10.94M | 11.77M | 12.26M | 12.35M |